Continuous Glucose Monitoring (CGM) – An Evolving Innovation Landscape
Published Date: 12.20.2024
Summary
Diabetes, particularly Type 2, is a prevalent chronic disease that disrupts the body’s blood sugar regulation, affecting millions globally.
Traditional monitoring methods, like finger-prick tests, provide limited snapshots of glucose levels, leaving a critical unmet need for ongoing data and personalized insights.
Continuous Glucose Monitors (CGMs) have revolutionized diabetes management by providing real-time, continuous glucose readings, trends, and alerts, empowering individuals to make informed decisions about diet, exercise, and medication.
This technology creates a massive market opportunity as the healthcare industry shifts towards preventative health and personalized medicine. Overall, the CGM market is projected to grow significantly, reaching a value of approximately $11.63 billion in 2024 and expanding to $21.32 billion by 2029